Core Laboratories (NYSE:CLB) Misses Q2 CY2026 Sales Expectations
Oilfield services company Core Laboratories NYSE:CLB fell short of the market’s revenue expectations in Q2 CY2026, with sales falling 4.3% year on year to $124.6 million. Its non-GAAP profit of $0.11 per share was 26.9% above analysts’ consensus estimates.Core Laboratories (CLB) Q2 CY2026 Highlight…